Advertisement

Topics

Peplin Limited Company Profile

07:43 EDT 18th June 2018 | BioPortfolio

Peplin Limited (Peplin) is a public company focused on the development and commercialisation of prescription human therapeutic products for the treatment of cancer. Peplin is listed on the Australian Stock Exchange (ASX:PEP) and has approximately 127 million shares on issue owned by over 3,000 shareholders. The company is based in Brisbane, Queensland, Australia. Peplin's core technology is a novel class of naturally occurring compounds which show significant potential as anti-cancer agents for a wide range of human cancers. The lead compound in this technology (PEP005) has demonstrated significant promise in a phase IIa clinical trial for actinic keratosis (AK) and in a pilot clinical trial as a topical agent against non-melanoma skin cancer conducted in 1999-2002. Peplin has extensive international patent coverage over its technologies.Peplin's vision is to deliver superior returns to shareholders through a focus on developing and commercialising products for the global market. Peplin's initial goal is to dominate the skin cancer market by delivering a novel product for the treatment of skin cancer.
Peplin will build on that foundation to deliver market leading products for other types of cancer. Peplin's strategy is to accomplish the majority of its commercialisation activities at least for its lead product through collaborative arrangements with leading international pharmaceutical companies. As a component of its growth and development it will seek to participate in higher value downstream segments of the product

Location

Level 2Brisbane Portal
1 Breakfast Creek Road
Newstead
Brisbane Queensland
4006
Australia

Contact

Fax: 61-7-3250 1299 / (07) 3250 1299
Email: info@peplin.com


News Articles [30 Associated News Articles listed on BioPortfolio]

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Quotient Limited to Participate in the 36th Annual J.P. Morgan Healthcare Conference

JERSEY, Channel Islands, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive ...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced it has entered into definitive agreements for t...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [85 Associated Companies listed on BioPortfolio]

Peplin Limited

Peplin Limited (Peplin) is a public company focused on the development and commercialisation of prescription human therapeutic products for the treatment of cancer. Peplin is listed on the Australian ...

Peplin, Inc.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Peplin Limited" on BioPortfolio

We have published hundreds of Peplin Limited news stories on BioPortfolio along with dozens of Peplin Limited Clinical Trials and PubMed Articles about Peplin Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Peplin Limited Companies in our database. You can also find out about relevant Peplin Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record